Clinical Trial Update: Safety and Efficacy of Itacitinib in Participants With Bronchiolitis Obliterans Syndrome Following Lung Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Itacitinib was studied for safety and efficacy in Bronchiolitis Obliterans Syndrome after lung transplantation. The Phase 1/2 trial was terminated and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans Syndrome

Drugs mentioned

• Itacitinib (itacitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Bronchiolitis Obliterans Syndrome | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-01-29